关于公司
- 法定名称: NAGASE Europa GmbH
- 注册国家: Germany
- 地址: Immermannstr.65c
- 员工人数: 50 - 99
描述:
Established in 1832. Net sales of US$8billion. Highly technically oriented manufacturer. Production of oncology injection, sterile dosage, spray-drying technology, Intermediate, API and excipient. Nagase Medicals, a sterile dosage manufacturer,?completed a new building dedicated for oncology injection and liposomal dosage. Hayashibara, joined Nagase group in February 2012, is only one manufacturer of Trehalose and Pullulan in the world.
业务活动
原料药 (API)
制造商
合同与外包服务
经销商
医药化学品
经销商
生物制药产品
经销商
原研原料药
经销商
销售市场
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
我们的产品与服务
Certifications
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论